AzTrials
AzTrials

Dental ImplantsNCT02139748

The Clinical Effect of Implant Placement With a Simultaneous Soft Tissue Allograft

A study testing Dental Implant & ADM and Dental Implant & ADM & bone xenograft in people with Dental Implants, run by University of Louisville at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Dental implant placement and simultaneous grafting using one layer gum graft will result in the same facial ridge contour and soft tissue thickness as one layer of gum graft plus bone graft. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Dental Implants
What is being tested?
Dental Implant & ADM and Dental Implant & ADM & bone xenograft
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28 participants
Where
1 siteUnited States
Study dates
Jul 2014to May 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Have one edentulous site bordered by 2 teeth in maxillary sites from second premolar to second premolar (maxillary 4 to 13) to receive an implant with simultaneous grafting with an ADM with or without bovine-derived xenograft.
  • Healthy persons at least 18 years old.
  • Understands and has signed the informed consent.

Who cannot join

  • Patients with uncontrolled diabetes, immune disease, or any systemic disease that significantly affects the periodontium.
  • Previous head and neck radiation.
  • Patients who have taken oral bisphosphonates for > 3 years or any IV bisphosphonates.
  • Smokers (or other tobacco habits that might interfere with soft tissue healing).
  • Patients who need prophylactic antibiotics prior to dental procedures.
  • Patients with allergies to any medication or material used in the study, or that would adversely affect study procedures.
Show all 15Show fewer
  • Chemotherapy in the previous 12 months.
  • Psychological problems that would interfere with treatment.
  • Patients unable or unwilling to sign the informed consent.
  • Pregnant subjects will be excluded due to risk of miscarriage.
  • Post-treatment Exclusion Criteria
  • Failure of patient to follow treatment protocol.
  • Failure of implant to osseointegrate.
  • Failure of the allograft to heal.
  • Unanticipated healing complications that will adversely affect treatment results.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Graduate Periodontics, University of Louisville School of Dentistry

    Louisville, Kentucky, 40292

Other trials in United States

About this study

Official title: The Clinical Effect of Implant Placement and Simultaneous Grafting Using Acellular Dermal Matrix Allograft vs. Acellular Dermal Matrix Allograft Plus Bovine-Derived Xenograft

Dental implant placement and simultaneous grafting using one layer gum graft will result in the same facial ridge contour and soft tissue thickness as one layer of gum graft plus bone graft.

Read the detailed description

30 patients will have a dental implant placed in maxillary sites from teeth number 4 to 13. Any implant system is acceptable since the objective of the study is to evaluate soft tissue thickness due to graft placement, not to evaluate the implant. 15 patients will be randomly selected by a coin toss to receive a one layer of ADM (Control Group) while another fifteen will receive one layer of ADM and bovine-derived xenograft (Test Group). The graft will be placed simultaneously with the dental implant. A blinded examiner will be used. Should the examiner become unblinded the subject will be excluded from the study.

Each patient will receive a diagnostic work-up including standardized radiographs (periapicals), study casts, clinical photographs, and a periodontal examination. Presurgical preparation will include detailed oral hygiene instructions. Baseline data will be collected at initial exam. Parameters measured will include: plaque index, gingival index, probing depth, keratinized tissue, bleeding on probing, adjacent tooth recession, radiographic examination, tissue esthetics, colors, contours, and clinical photographs will be taken at baseline, during surgery and post-op visits.

The treatment will be randomly assigned using a coin toss. The mentor will flip the coin. The surgical procedure will consist of the reflection of full thickness flaps to expose the buccal crest. A dental implant will be placed in the edentulous site. Any implant system will be acceptable since the objective of the study is to evaluate soft tissue thickness and contour, not the dental implant. Either one layer of ADM or one layer of ADM plus bovine-derived xenograft (BX) will be placed following implant placement on the buccal aspect of the implant. When one layer of ADM is used it will be placed on the buccal surface of the implant only. When one layer of ADM and BX are used the BX will be overlaid buccal to the implant, then covered by ADM. Thus the buccal surface will have either one layer of ADM or one layer of ADM with BX. The surgical procedures will be documented with clinical photographs. Records will be kept of healing every 2 weeks for the first 8 weeks, then at 4 months or 16 weeks. At the end of 16 weeks or 4 months, once the study is completed, post and crown procedure over the implant can be started.

To provide adequate room to establish emergence profile the implant platform should be 3 to 4 mm apical to the mid-facial gingival margin when a 2-stage dental implant system is used. This may require reduction of the osseous crest by scalloping the bone so that the mid-facial osseous crest is 3-4 mm apical to the mid-facial gingival margin. This may result in a sub-crestal position of the interproximal implant platform (measured as a negative number). The top of the implant will be even with the crestal bone. The implant used will be any dental implant. At the time of surgery the implant platform will be placed even with the mid-facial osseous crest if a two-stage implant is used.

All probing measurements will be taken using the University of North Carolina probe. One investigator who is unaware of group assignment will perform all baseline examinations and all follow-up examinations. He will be calibrated prior to study initiation to assure that evaluations are consistent. The surgeon will perform all surgical procedures and will know the group to which each participant has been assigned. Standardized periapical radiographs will be taken at implant placement and at the 4-month examinations.

All patients will be seen at 1-2, 3-4, 5-6 and 7-8, and 16 weeks and buccal, occlusal and lingual clinical photographs will be taken at each visit. Patients will take doxycycline hyclate 100 mg qd for two weeks, Vicodin ES q4-6h as needed for pain, and naproxen 375 mg q12h for one week for inflammation. At post-operative visits plaque removal, and oral hygiene instruction, as needed, will be performed along with clinical photographs and standardized radiographs as scheduled.

Conditions
Dental Implants
Being tested
Dental Implant & ADM, Dental Implant & ADM & bone xenograft
Keywords
Dental Implants, Alveolar Bone Grafting, Acellular Dermis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dental Implant & ADMProcedure or surgery

    A dental implant will be placed and the buccal soft tissue will be grafted using an acellular dermal matrix allograft.

  • Dental Implant & ADM & bone xenograftProcedure or surgery

    A dental implant will be placed along with a buccal acellular dermal matrix allograft which will cover a bone xenograft.

Study groups in NCT02139748
Study groupRoleWhat they receive
Dental Implant & ADMActive comparatorDental implant placement plus simultaneous grafting use one layer of ADM.
Receives: Procedure: Dental Implant & ADM
Dental Implant & ADM & bone xenograftExperimentalDental implant placement plus simultaneous grafting use one layer of ADM with bovine xenograft.
Receives: Procedure: Dental Implant & ADM; Procedure: Dental Implant & ADM & bone xenograft

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Buccal soft tissue contour around dental implant.

    Contour will be categorized as concave, flat, or convex (subjective categories).

    Measured: 4 months post dental implant placement.

Secondary outcomes (2)
  1. Buccal soft tissue thickness around dental implant.

    Thickness will be measured with an endodontic file using a rubber stopper (objective measure of tissue thickness by penetrating tissue and measuring the thickness in mm).

    Measured: 4 months post dental implant placement.

  2. Buccal soft tissue healing around dental implant.

    The outcomes will be categorized as normal, delayed or accelerated (subjective assessment and assignment to a category).

    Measured: 4 months post dental implant placement.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 May 2014 (estimated)
  2. Study startJul 2014
  3. Primary completionMay 2015
  4. Study completionMay 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
28 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02139748
Sponsor's protocol ID
14.0387
Status last verified
May 2014
First submitted
25 Apr 2014
Last updated
8 Dec 2016
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Dental Implant & ADM and Dental Implant & ADM & bone xenograft in people with Dental Implants, run by University of Louisville at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Dec 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Buccal soft tissue contour around dental implant. (time frame: 4 months post dental implant placement.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in